Literature DB >> 10451958

[The association of HLA-DR4 gene subtypes with Vogt-Koyanagi-Harada syndrome].

T Xiao1, Y Jiang, X You.   

Abstract

OBJECTIVE: To investigate the association of HLA-DR4 subtypes with Vogt-Koyanagi-Harada (VKH) syndrome and to clarify immune genetic mechanism underlying the susceptibility/resistance to VKH syndrome.
METHODS: HLA-DR4 alleles of 54 patients with VKH and 106 healthy controls were amplified and subtyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
RESULTS: A selective amplification of the DR4 alleles of 263 bp was higher in patients with VKH than in the controls. The frequency of DR4-DRB1 alleles was 70% (38/54) in VKH group and was 19% (20/106) in the control group, relative rish (RR) = 10.21, P < 0.005. The genotyping of DR4 alleles showed that DRB1 * 0405 was more frequent in VKH group (35/38, 92%) than in the control group [6/20, 30%, RR = 27.2, P = 0.0,000,017, corrected pvalue (Pc) = 0.0,000,103].
CONCLUSIONS: It is suggested that DRB1 * 0405 be a susceptible subtype to VKH and the specific amino acid residue Ser (serine) at position 57 play an important role in the development of VKH syndrome. The molecular biological technique we used may be useful in studying the immunogenetic mechanism of VKH.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10451958

Source DB:  PubMed          Journal:  Zhonghua Yan Ke Za Zhi        ISSN: 0412-4081


  3 in total

Review 1.  Association of HLA-DR4/HLA-DRB1*04 with Vogt-Koyanagi-Harada disease: a systematic review and meta-analysis.

Authors:  Tingkun Shi; Wenjuan Lv; Li Zhang; Jianhuan Chen; Haoyu Chen
Journal:  Sci Rep       Date:  2014-11-10       Impact factor: 4.379

2.  Small ubiquitin-like modifier 4 (SUMO4) polymorphisms and Vogt-Koyanagi-Harada (VKH) syndrome in the Chinese Han population.

Authors:  Shengping Hou; Peizeng Yang; Liping Du; Hongyan Zhou; Xiaomin Lin; Xiaoli Liu; Aize Kijlstra
Journal:  Mol Vis       Date:  2008-12-31       Impact factor: 2.367

3.  Polymorphisms of FCRL3 in a Chinese population with Vogt-Koyanagi-Harada (VKH) syndrome.

Authors:  Ke Li; Peizeng Yang; Min Zhao; Shengping Hou; Liping Du; Hongyan Zhou; Aize Kijlstra
Journal:  Mol Vis       Date:  2009-05-11       Impact factor: 2.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.